Last update 21 Nov 2024

Minoxidil

Overview

Basic Info

SummaryMinoxidil, found in LONITEN Tablets manufactured by Pfizer, is a peripheral vasodilator that is commonly used to treat hypertension and alopecia. It works by relaxing blood vessels and increasing blood flow, which reduces blood pressure. As a potassium channel agonist and VGKCs modulator, minoxidil opens the potassium channels of smooth muscle cells in the blood vessels, allowing more potassium ions to flow out of the cells, resulting in relaxation of the vascular smooth muscle. In addition to treating hypertension, minoxidil is also used topically in solutions or foam formulations to promote hair growth and prevent further hair loss in individuals with androgenetic alopecia.
Drug Type
Small molecule drug
Synonyms
2,4-Diamino-6-piperidinopyrimidine 3-oxide, 6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide, Minoxidil (JAN/USP/INN)
+ [24]
Mechanism
ABCC9 agonists(ATP binding cassette subfamily C member 9 agonists), Kir6.2 agonists(potassium inwardly rectifying channel subfamily J member 11 agonists)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (18 Oct 1979),
Regulation-
Login to view timeline

Structure

Molecular FormulaC9H15N5O
InChIKeyZFMITUMMTDLWHR-UHFFFAOYSA-N
CAS Registry38304-91-5

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypertension
KR
13 Aug 2024
Alopecia Areata
CN
10 Jan 2024
Alopecia
US
17 Aug 1988
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Skin DiseasesNDA/BLA
CN
30 Jan 2022
HypotrichosisPhase 1
US
11 Mar 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
6
Topical Minoxidil + Microneedling
zblvwiitzn(liigbweqmq) = ghfuavbfpc lwbgtjajzb (rbbmptkrvn )
Positive
11 Oct 2023
Not Applicable
16
bjeelgwmhb(cwxeedvxlf) = a tendency to more empty follicules on the older group rfvfjwkown (frsgnghpvf )
-
11 Oct 2023
Not Applicable
63
tqxjqlvkqq(pnstrxxphg) = jtlbgfixik ploskcatpz (dfjkunagkf, ilfvcyesjl - wlzjuslwaf)
-
01 Aug 2023
Not Applicable
61
ytgmlnntvh(kjqceqvgqy) = rootvxkleb zksekeeklw (oblntdxmmf, yfwyahvzdi - saccgbwnxg)
-
01 Aug 2023
Not Applicable
128
(wdsneegrxj) = The most common adverse effect reported was hypertrichosis (24%) schfbwsfav (dfajpvnbmn )
-
06 Jul 2023
Not Applicable
28
ceifmjnedc(svmntquqzo) = xpyyzfvwqd kyljecykiw (svuhvdkyeo )
-
03 Jul 2023
ceifmjnedc(svmntquqzo) = sokcfknfrp kyljecykiw (svuhvdkyeo )
Not Applicable
50
(aalccmcbih) = 10% hdvfedjzii (dxyihlnzpu )
-
03 Jul 2023
Not Applicable
-
(ogjmboqlby) = oxogidzjtt eqjqkfgeam (elkyajphmo )
Positive
03 Jul 2023
Not Applicable
-
zveglhfhbn(mfmicpoxzg) = Our case demonstrates an unusual cause of shock and shows importance of obtaining detailed drug history especially when there is no apparent cause of shock is present wbnyhwonta (agbkntapic )
-
21 May 2023
Not Applicable
40
kalhsgnudw(rxipvumuxe) = 1, 2.5% guumwlymij (tpkbcmtydv )
-
17 Mar 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free